Use UNICORN Signals App By EquityPandit
Latest News

Glenmark Pharma gets approval for skin treatment cream from USFDA

Glenmark Pharmaceuticals has received final approval for the generic version of Temovate cream used to treat inflammation and itching caused by a number of skin conditions, from the US health regulator.

In a BSE filing the company stated, “Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Clobetasol Propionate cream USP, 0.05%, the generic version of Temovate Cream, 0.05% of Fougera pharmaceuticals.”

Moreover, the company’s current portfolio consists of 134 products authorized for distribution at the US marketplace and 61 abbreviated new drug applications (ANDA) pending approval with the USFDA.

Read EquityPandit’s Technical Analysis of Nifty Pharma

Get Daily Prediction & Stocks Tips On Your Mobile


Latest
IPO
Weekly
Outlook

Stock
Market
Prediction